Stay updated with the latest news and articles about Sun Pharmaceutical Industries.
The trial, conducted across Germany, France, Italy, Spain, and Poland, has exceeded its enrollment target with 129 patients enrolled against the planned 118. Key results from this study are anticipated between March and June 2025.
Sales of Sun Pharma's formulations in India increased 5.1% to ₹3,560.4 crore. US formulation sales reached $471 million, a 12% YoY increase. More over one-third of the company's total consolidated sales came from sales in the US.
Concert is a biotechnology business in its late stages that is pioneering the use of deuterium in medicinal chemistry.